1-1 of 1
Sigal Tavor
Close
Sort by
Journal Articles

BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a study

Clinical Trials & Observations
Tsila Zuckerman, Ron Ram, Luiza Akria, Maya Koren-Michowitz, Ron Hoffman, Israel Henig, Noa Lavi, Yishai Ofran, Netanel A. Horowitz, Olga Nudelman, Sigal Tavor, Shay Yeganeh, Stela Gengrinovitch, Liat Flaishon, Shoshi Tessler, Ruth Ben Yakar, Jacob M. Rowe
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3740–3749.
https://doi.org/10.1182/bloodadvances.2019000468
Published: 2019
Includes: Supplemental data